"Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Revascularization Patients

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
This study aims to evaluate the effect of an AI-assisted \"Smart family doctor\" digital health management tool on improving the control rates of hypertension, diabetes, and dyslipidemia in post-revascularization patients. A randomized controlled trial design will be used, involving approximately 10-20 hospitals and 951 participants. Eligible participants are adults aged between 18 and 80 years, post-CABG or post-PCI patients with hypertension, diabetes, and dyslipidemia.
Epistemonikos ID: b35acf53bc9770eeb0aec9162e33fab2e64d8d8d
First added on: Dec 10, 2025